Cell delivery routes for stem cell therapy to the heart: current and future approaches. (Q38014708)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Cell delivery routes for stem cell therapy to the heart: current and future approaches (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Ken Suzuki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

31 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cardiovascular Translational Research

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

713-726

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up.

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Choice of cell-delivery route for skeletal myoblast transplantation for treating post-infarction chronic heart failure in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Novel percutaneous adventitial drug delivery system for regional vascular treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Transvenous intramyocardial cellular delivery increases retention in comparison to intracoronary delivery in a porcine model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Direct intramyocardial but not intracoronary injection of bone marrow cells induces ventricular arrhythmias in a rat chronic ischemic heart failure model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Four-year follow-up of treatment with intramyocardial skeletal myoblasts injection in patients with ischaemic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

A factor underlying late-phase arrhythmogenicity after cell therapy to the heart: global downregulation of connexin43 in the host myocardium after skeletal myoblast transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Minimally invasive epicardial injections using a novel semiautonomous robotic device

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Injectable biopolymers enhance angiogenesis after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Quantitative assessment of initial retention of bone marrow mononuclear cells injected into the coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Dynamic tracking during intracoronary injection of 18F-FDG-labeled progenitor cell therapy for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intra-coronary arterial injection of mesenchymal stromal cells and microinfarction in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

RETRACTED: Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Role of balloon occlusion for mononuclear bone marrow cell deposition after intracoronary injection in pigs with reperfused myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

VEGF improves survival of mesenchymal stem cells in infarcted hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Cardiac tissue engineering: current state and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Cell sheet engineering: a unique nanotechnology for scaffold-free tissue reconstruction with clinical applications in regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Cell sheet engineering: recreating tissues without biodegradable scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Cardiomyocyte bridging between hearts and bioengineered myocardial tissues with mesenchymal transition of mesothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Composite cell sheets: a further step toward safe and effective myocardial regeneration by cardiac progenitors derived from embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Impaired myocardium regeneration with skeletal cell sheets--a preclinical trial for tissue-engineered regeneration therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Autologous bone marrow mononuclear cell transplantation in patients undergoing coronary artery bypass grafting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Recovery of regional but not global contractile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Regeneration of human infarcted heart muscle by intracoronary autologous bone marrow cell transplantation in chronic coronary artery disease: the IACT Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Transcoronary transplantation of progenitor cells after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

The BALANCE Study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

The acute and long-term effects of intracoronary Stem cell Transplantation in 191 patients with chronic heARt failure: the STAR-heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Results of intracoronary stem cell therapy after acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Skeletal myoblast transplantation through a catheter-based coronary sinus approach: an effective means of improving function of infarcted myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12265-012-9378-3

[Regenerative therapy in patients with a revascularized acute anterior myocardial infarction and depressed ventricular function]

21 January 2018

1 reference

12 December 2020

Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials

1 reference

12 December 2020

Intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction: a prematurely terminated randomized study

1 reference

12 December 2020

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int

1 reference

12 December 2020

Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice

1 reference

12 December 2020

A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction

1 reference

12 December 2020

Percutaneous transvenous cellular cardiomyoplasty. A novel nonsurgical approach for myocardial cell transplantation

1 reference

12 December 2020

Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution

1 reference

12 December 2020

The effects of intracoronary delivery of mononuclear bone marrow cells in patients with myocardial infarction: a two year follow-up results.

1 reference

12 December 2020

Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium

1 reference

12 December 2020

Repeated Intracoronary Infusion of Peripheral Blood Stem Cells With G-CSF in Patients With Refractory Ischemic Heart Failure - A Pilot Study -

1 reference

12 December 2020

111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model.

1 reference

12 December 2020

The clinical study of autologous peripheral blood stem cell transplantation by intracoronary infusion in patients with acute myocardial infarction (AMI)

1 reference

12 December 2020

Stem cell treatment for acute myocardial infarction

1 reference

12 December 2020

Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart

1 reference

12 December 2020

Influence of bone marrow stem cells on left ventricle perfusion and ejection fraction in patients with acute myocardial infarction of anterior wall: randomized clinical trial: Impact of bone marrow stem cell intracoronary infusion on improvement of

1 reference

12 December 2020

Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.

1 reference

12 December 2020

Autologous bone-marrow stem-cell transplantation for myocardial regeneration

1 reference

12 December 2020

Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies

1 reference

12 December 2020

Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart.

1 reference

12 December 2020

Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging

1 reference

12 December 2020

Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction

1 reference

12 December 2020

The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial a long-term follow-up study

1 reference

12 December 2020

Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction

1 reference

12 December 2020

Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study

1 reference

12 December 2020

Intramyocardial angiogenic cell precursor injection for cardiomyopathy

1 reference

12 December 2020

Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease

1 reference

12 December 2020

Intracoronary stem-cell injection after myocardial infarction: microcirculation sub-study

1 reference

12 December 2020

Percutaneous adventitial delivery of allogeneic bone marrow-derived stem cells via infarct-related artery improves long-term ventricular function in acute myocardial infarction

1 reference

12 December 2020

10.1007/S12265-012-9378-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 February 2020

1010470751

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22648235%20AND%20SRC:MED&resulttype=core&format=json